ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,558,000 | -27.7% | 73,662 | -4.1% | 0.02% | -34.8% |
| Q1 2021 | $2,155,000 | +2.2% | 76,831 | -5.2% | 0.02% | -4.2% |
| Q4 2020 | $2,108,000 | -31.5% | 81,083 | -2.1% | 0.02% | -41.5% |
| Q3 2020 | $3,077,000 | +6.8% | 82,790 | +47.4% | 0.04% | 0.0% |
| Q2 2020 | $2,881,000 | +183.6% | 56,150 | +74.3% | 0.04% | +141.2% |
| Q1 2020 | $1,016,000 | -38.8% | 32,220 | +58.6% | 0.02% | -52.8% |
| Q2 2015 | $1,661,000 | -11.7% | 20,317 | 0.0% | 0.04% | -12.2% |
| Q1 2015 | $1,881,000 | – | 20,317 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |